Stephan Harbarth

Author PubWeight™ 147.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005 5.86
2 Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006 4.15
3 Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis 2010 3.65
4 Meticillin-resistant Staphylococcus aureus. Lancet Infect Dis 2005 3.18
5 Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action. Antimicrob Resist Infect Control 2012 3.02
6 Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2007 2.88
7 Health-care workers: source, vector, or victim of MRSA? Lancet Infect Dis 2008 2.79
8 Society's failure to protect a precious resource: antibiotics. Lancet 2011 2.51
9 Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries. Clin Infect Dis 2009 2.39
10 Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis 2004 2.35
11 Livestock-associated methicillin-resistant Staphylococcus aureus in humans, Europe. Emerg Infect Dis 2011 2.35
12 Low apolipoprotein A-I level at intensive care unit admission and systemic inflammatory response syndrome exacerbation. Crit Care Med 2004 2.33
13 A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection. Clin Infect Dis 2004 2.22
14 Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis 2007 2.11
15 Evaluation of three molecular assays for rapid identification of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2007 1.97
16 A call for action: the application of The International Health Regulations to the global threat of antimicrobial resistance. PLoS Med 2011 1.88
17 Use of an automated multiple-locus, variable-number tandem repeat-based method for rapid and high-throughput genotyping of Staphylococcus aureus isolates. J Clin Microbiol 2005 1.88
18 Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. Crit Care 2006 1.70
19 A novel multiplex real-time PCR assay for rapid typing of major staphylococcal cassette chromosome mec elements. J Clin Microbiol 2004 1.63
20 Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. Clin Infect Dis 2011 1.62
21 Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. J Antimicrob Chemother 2008 1.60
22 Quantifying uncertainty: physicians' estimates of infection in critically ill neonates and children. Clin Infect Dis 2004 1.57
23 Is throat screening necessary to detect methicillin-resistant Staphylococcus aureus colonization in patients upon admission to an intensive care unit? J Clin Microbiol 2007 1.51
24 Use of benchmarking and public reporting for infection control in four high-income countries. Lancet Infect Dis 2011 1.50
25 Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care 2005 1.49
26 Prevalence and prediction of previously unknown MRSA carriage on admission to a geriatric hospital. Age Ageing 2005 1.27
27 Should this event be notified to the World Health Organization? Reliability of the international health regulations notification assessment process. Bull World Health Organ 2011 1.27
28 Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated diarrhea in hospitalized patients. Antimicrob Agents Chemother 2009 1.22
29 Methicillin-resistant Staphylococcus aureus, Geneva, Switzerland, 1993-2005. Emerg Infect Dis 2008 1.21
30 Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected? Clin Infect Dis 2009 1.19
31 The environment and healthcare-acquired infections: why accurate reporting and evaluation of biological plausibility are important. Infect Control Hosp Epidemiol 2013 1.15
32 Cost implications of successful hand hygiene promotion. Infect Control Hosp Epidemiol 2004 1.15
33 Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective. Drug Resist Updat 2011 1.14
34 Time-dependent study entries and exposures in cohort studies can easily be sources of different and avoidable types of bias. J Clin Epidemiol 2012 1.13
35 Comparison of strategies to reduce meticillin-resistant Staphylococcus aureus rates in surgical patients: a controlled multicentre intervention trial. BMJ Open 2013 1.11
36 Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community. J Antimicrob Chemother 2011 1.10
37 Priority actions to fight antibiotic resistance: results of an international meeting. Antimicrob Resist Infect Control 2012 1.10
38 Bench-to-bedside review: Rapid molecular diagnostics for bloodstream infection--a new frontier? Crit Care 2012 1.08
39 Epidemiology of methicillin-resistant Staphylococcus aureus: results of a nation-wide survey in Switzerland. Swiss Med Wkly 2002 1.08
40 Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures. Infect Control Hosp Epidemiol 2011 1.06
41 Use of oligoarrays for characterization of community-onset methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2006 1.05
42 Effect of individual- and group-level antibiotic exposure on MRSA isolation: a multilevel analysis. J Antimicrob Chemother 2006 1.04
43 Estimating the cost of health care-associated infections: mind your p's and q's. Clin Infect Dis 2010 1.02
44 Rapid identification of hospitalized patients at high risk for MRSA carriage. J Am Med Inform Assoc 2008 1.02
45 Antibiotic consumption, bacterial resistance and their correlation in a Swiss university hospital and its adult intensive care units. Scand J Infect Dis 2003 1.02
46 Control of methicillin-resistant Staphylococcus aureus. Infect Dis Clin North Am 2011 1.01
47 Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance. Clin Microbiol Rev 2013 1.01
48 Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study. Crit Care 2014 1.00
49 Rapid Staphylococcus aureus agr type determination by a novel multiplex real-time quantitative PCR assay. J Clin Microbiol 2006 1.00
50 Dissemination and sustainability of a hospital-wide hand hygiene program emphasizing positive reinforcement. Infect Control Hosp Epidemiol 2010 0.99
51 Activity and impact on antibiotic use and costs of a dedicated infectious diseases consultant on a septic orthopaedic unit. J Infect 2009 0.99
52 High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2011 0.99
53 An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units. J Antimicrob Chemother 2014 0.98
54 Impact of the French campaign to reduce inappropriate ambulatory antibiotic use on the prescription and consultation rates for respiratory tract infections. J Antimicrob Chemother 2011 0.97
55 Evaluation of molecular assays for rapid detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2010 0.97
56 Preventing surgical site infections. Expert Rev Anti Infect Ther 2010 0.97
57 Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia. Clin Infect Dis 2012 0.97
58 The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings. Br J Clin Pharmacol 2012 0.96
59 Nursing resources: a major determinant of nosocomial infection? Curr Opin Infect Dis 2004 0.95
60 The PIRO concept: R is for response. Crit Care 2003 0.94
61 At least it won't hurt: the personal risks of antibiotic exposure. Curr Opin Pharmacol 2011 0.93
62 Daily chlorhexidine bathing and hospital-acquired infection. N Engl J Med 2013 0.93
63 Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial. J Antimicrob Chemother 2013 0.92
64 The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study. Euro Surveill 2016 0.92
65 Rapid and high-throughput genotyping of Staphylococcus epidermidis isolates by automated multilocus variable-number of tandem repeats: a tool for real-time epidemiology. J Microbiol Methods 2008 0.91
66 Effect of design-related bias in studies of diagnostic tests for ventilator-associated pneumonia. Am J Respir Crit Care Med 2002 0.91
67 Is patient isolation the single most important measure to prevent the spread of multidrug-resistant pathogens? Virulence 2013 0.90
68 Complete Genome Sequences of Nitrofurantoin-Sensitive and -Resistant Escherichia coli ST540 and ST2747 Strains. Genome Announc 2014 0.90
69 G-CSF and IL-8 for early diagnosis of sepsis in neonates and critically ill children - safety and cost effectiveness of a new laboratory prediction model: study protocol of a randomized controlled trial [ISRCTN91123847]. Crit Care 2004 0.90
70 Methicillin-resistant Staphylococcus aureus control in the 21st century: beyond the acute care hospital. Curr Opin Infect Dis 2008 0.89
71 Estimating attributable mortality due to nosocomial infections acquired in intensive care units. Infect Control Hosp Epidemiol 2010 0.89
72 De-escalation as a potential way of reducing antibiotic use and antimicrobial resistance in ICU. Intensive Care Med 2014 0.88
73 Fighting bacterial resistance at the root: need for adapted EMEA guidelines. Lancet Infect Dis 2011 0.87
74 "Antibiotics are not automatic anymore"--the French national campaign to cut antibiotic overuse. PLoS Med 2009 0.87
75 Effect of a comprehensive, multidisciplinary, educational program on the use of antibiotics in a geriatric university hospital. J Am Geriatr Soc 2004 0.87
76 Burden of bloodstream infection caused by extended-spectrum β-lactamase-producing enterobacteriaceae determined using multistate modeling at a Swiss University Hospital and a nationwide predictive model. Infect Control Hosp Epidemiol 2012 0.87
77 Hand hygiene practices and adherence determinants in surgical wards across Europe and Israel: a multicenter observational study. Am J Infect Control 2011 0.86
78 Bacteremic sepsis in intensive care: temporal trends in incidence, organ dysfunction, and prognosis. Crit Care Med 2003 0.85
79 Long-term reduction of vascular access-associated bloodstream infection. Ann Intern Med 2005 0.85
80 Valuation of hospital bed-days released by infection control programs: a comparison of methods. Infect Control Hosp Epidemiol 2014 0.85
81 Navigating the Web in search of resources on antimicrobial stewardship in health care institutions. Clin Infect Dis 2009 0.85
82 Prevention of primary bacteraemia. Int J Antimicrob Agents 2007 0.84
83 Acute respiratory distress syndrome after bacteremic sepsis does not increase mortality. Am J Respir Crit Care Med 2003 0.84
84 The Potential Role of Social Media Platforms in Community Awareness of Antibiotic Use in the Gulf Cooperation Council States: Luxury or Necessity? J Med Internet Res 2015 0.84
85 A simulation-based evaluation of methods to estimate the impact of an adverse event on hospital length of stay. Med Care 2007 0.84
86 Improved treatment of multidrug-resistant bacterial infections: utility of clinical studies. Future Microbiol 2014 0.84
87 Cefuroxime prophylaxis is effective in noninstrumented spine surgery: a double-blind, placebo-controlled study. Spine (Phila Pa 1976) 2008 0.84
88 Epidemiology and acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a septic orthopedic ward. Springerplus 2013 0.84
89 Multilevel competing risk models to evaluate the risk of nosocomial infection. Crit Care 2014 0.83
90 Low risk despite high endemicity of methicillin-resistant Staphylococcus aureus infections following elective total joint arthroplasty: a 12-year experience. Ann Med 2011 0.83
91 Diagnostic accuracy of G-CSF, IL-8, and IL-1ra in critically ill children with suspected infection. Intensive Care Med 2002 0.83
92 Epidemiology of methicillin-resistant Staphylococcus aureus carriage and MRSA surgical site infections in patients undergoing colorectal surgery: a cohort study in two centers. Surg Infect (Larchmt) 2012 0.82
93 Should the methicillin-resistant Staphylococcus aureus carriage status be used as a guide to treatment for skin and soft tissue infections? J Infect 2012 0.82
94 Impact of outpatient antibiotic use on carriage of ampicillin-resistant Escherichia coli. Antimicrob Agents Chemother 2010 0.82
95 An outbreak of Pseudomonas aeruginosa pneumonia and bloodstream infection associated with intermittent otitis externa in a healthcare worker. Infect Control Hosp Epidemiol 2004 0.81
96 "Ten Commandments" for the Appropriate use of Antibiotics by the Practicing Physician in an Outpatient Setting. Front Microbiol 2011 0.81
97 Postoperative serum pro-calcitonin and C-reactive protein levels in patients with orthopedic infections. Swiss Med Wkly 2010 0.80
98 The importance of good data, analysis, and interpretation for showing the economics of reducing healthcare-associated infection. Infect Control Hosp Epidemiol 2011 0.80
99 Antibiotic therapy in patients hospitalized with acute chronic obstructive pulmonary disease. JAMA 2010 0.80
100 Procalcitonin levels during pregnancy, delivery and postpartum. J Perinat Med 2011 0.80
101 Transmission and effect of multiple clusters of seasonal influenza in a Swiss geriatric hospital. J Am Geriatr Soc 2015 0.80
102 Community-acquired methicillin-resistant Staphylococcus aureus infections in two scuba divers returning from the Philippines. J Travel Med 2008 0.79
103 Screening for methicillin-resistant Staphylococcus aureus … all doors closed? Curr Opin Infect Dis 2014 0.78
104 Genotypic and phenotypic analysis of Clostridium difficile correlated with previous antibiotic exposure. Microb Drug Resist 2006 0.78
105 [Urinary tract infections in adults]. Rev Med Suisse 2011 0.77
106 Methicillin-resistant Staphylococcus aureus decolonization: "yes, we can," but will it help? Infect Control Hosp Epidemiol 2009 0.77
107 Control of MRSA in intensive care units. BMJ 2011 0.77
108 Does colonization with methicillin-susceptible Staphylococcus aureus protect against nosocomial acquisition of methicillin-resistant S. aureus? Infect Control Hosp Epidemiol 2014 0.77
109 Molecular and epidemiological evaluation of strain replacement in patients previously harboring gentamicin-resistant MRSA. J Clin Microbiol 2011 0.77
110 Infection control measures to decrease the burden of antimicrobial resistance in the critical care setting. Curr Opin Crit Care 2014 0.76
111 Infection control interventions in small rural hospitals with limited resources: results of a cluster-randomized feasibility trial. Antimicrob Resist Infect Control 2014 0.76
112 Extended-spectrum β-lactamase-producing Enterobacteriaceae in hospital food: a risk assessment. Infect Control Hosp Epidemiol 2014 0.76
113 Molecular characteristics of community-associated methicillin-resistant Staphylococcus aureus colonizing surgical patients in Greece. Diagn Microbiol Infect Dis 2012 0.76
114 Pseudomonas aeruginosa outbreak in a pediatric intensive care unit linked to a humanitarian organization residential center. Pediatr Infect Dis J 2010 0.76
115 Comment on: Control of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae using a computer-assisted management program to restrict third-generation cephalosporin use. J Antimicrob Chemother 2008 0.75
116 Year in review 2010: Critical Care--Infection. Crit Care 2011 0.75
117 Guidelines for vancomycin use. Clin Infect Dis 2010 0.75
118 Methicillin-resistant Staphylococcus aureus risk profiling: who are we missing? Antimicrob Resist Infect Control 2013 0.75
119 Is anti-tumor necrosis factor therapy associated with increased mortality in patients with severe sepsis caused by pneumonia? J Infect Dis 2004 0.75
120 Control of nosocomial methicillin-resistant Staphylococcus aureus: where shall we send our hospital director next time? Infect Control Hosp Epidemiol 2003 0.75
121 Assisted knowledge discovery for the maintenance of clinical guidelines. PLoS One 2013 0.75
122 Think (Gram) negative! Crit Care 2010 0.75
123 Beads vs bugs? Chest 2012 0.75
124 Procalcitonin as diagnostic biomarker of sepsis. Lancet Infect Dis 2013 0.75
125 Ethics roundtable debate: A patient dies from an ICU-acquired infection related to methicillin-resistant Staphylococcus aureus--how do you defend your case and your team? Crit Care 2004 0.75
126 Management of Gram-positive bacteraemia. Curr Opin Infect Dis 2007 0.75
127 [Clostridium difficile infections, specific issues in the elderly]. Rev Med Suisse 2013 0.75
128 [Patient management after splenectomy in 2015: state of the art and recommendations]. Rev Med Suisse 2015 0.75
129 Identifying antibiotic-resistant bacteria in hospitalized patients: what is the role of active-surveillance cultures? Clin Chem 2013 0.75
130 [Procalcitonin: should it be measured systemically?]. Rev Med Suisse 2013 0.75